U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C25H22BrF3N4O4S
Molecular Weight 611.431
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SAPRISARTAN

SMILES

CCC1=NC(C2CC2)=C(N1CC3=CC=C4OC(=C(Br)C4=C3)C5=CC=CC=C5NS(=O)(=O)C(F)(F)F)C(N)=O

InChI

InChIKey=DUEWVPTZCSAMNB-UHFFFAOYSA-N
InChI=1S/C25H22BrF3N4O4S/c1-2-19-31-21(14-8-9-14)22(24(30)34)33(19)12-13-7-10-18-16(11-13)20(26)23(37-18)15-5-3-4-6-17(15)32-38(35,36)25(27,28)29/h3-7,10-11,14,32H,2,8-9,12H2,1H3,(H2,30,34)

HIDE SMILES / InChI

Molecular Formula C25H22BrF3N4O4S
Molecular Weight 611.431
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Saprisartan (formerly known as GR 138950) was developed as a potent long-lasting angiotensin II (AT1) receptor antagonist with high oral bioavailability. The drug was used for the treatment of hypertension and heart failure. However, these studies were discontinued.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: P30556
Gene ID: 185.0
Gene Symbol: AGTR1
Target Organism: Homo sapiens (Human)
PubMed

PubMed

TitleDatePubMed
Bromobenzofuran-based non-peptide antagonists of angiotensin II: GR138950, a potent antihypertensive agent with high oral bioavailability.
1994 Sep 16
Pharmacological effects of GR138950, a novel angiotensin AT1 receptor antagonist.
1995 Feb
Investigation of the inhibitory effect of N(G)-nitro-L-arginine methyl ester on the antihypertensive effect of the angiotensin AT1 receptor antagonist, GR138950.
1997 Dec
The antihypertensive profile of the angiotensin AT1 receptor antagonist, GR138950, and the influence of potential homeostatic compensatory mechanisms in renal hypertensive rats.
1998 Nov
Patents
Substance Class Chemical
Created
by admin
on Fri Dec 15 18:52:01 UTC 2023
Edited
by admin
on Fri Dec 15 18:52:01 UTC 2023
Record UNII
HS64NG1G69
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
SAPRISARTAN
INN   WHO-DD  
INN  
Official Name English
GR138950
Code English
saprisartan [INN]
Common Name English
GR-138950
Code English
Saprisartan [WHO-DD]
Common Name English
3-((3-BROMO-2-(2-(TRIFLUOROMETHYLSULFONYLAMINO)PHENYL)-1-BENZOFURAN-5-YL)METHYL)-5-CYCLOPROPYL-2-ETHYLIMIDAZOLE-4-CARBOXAMIDE
Systematic Name English
Classification Tree Code System Code
NCI_THESAURUS C66930
Created by admin on Fri Dec 15 18:52:01 UTC 2023 , Edited by admin on Fri Dec 15 18:52:01 UTC 2023
Code System Code Type Description
FDA UNII
HS64NG1G69
Created by admin on Fri Dec 15 18:52:01 UTC 2023 , Edited by admin on Fri Dec 15 18:52:01 UTC 2023
PRIMARY
PUBCHEM
60921
Created by admin on Fri Dec 15 18:52:01 UTC 2023 , Edited by admin on Fri Dec 15 18:52:01 UTC 2023
PRIMARY
INN
7306
Created by admin on Fri Dec 15 18:52:01 UTC 2023 , Edited by admin on Fri Dec 15 18:52:01 UTC 2023
PRIMARY
EVMPD
SUB10444MIG
Created by admin on Fri Dec 15 18:52:01 UTC 2023 , Edited by admin on Fri Dec 15 18:52:01 UTC 2023
PRIMARY
CAS
146623-69-0
Created by admin on Fri Dec 15 18:52:01 UTC 2023 , Edited by admin on Fri Dec 15 18:52:01 UTC 2023
PRIMARY
ChEMBL
CHEMBL305544
Created by admin on Fri Dec 15 18:52:01 UTC 2023 , Edited by admin on Fri Dec 15 18:52:01 UTC 2023
PRIMARY
EPA CompTox
DTXSID00163422
Created by admin on Fri Dec 15 18:52:01 UTC 2023 , Edited by admin on Fri Dec 15 18:52:01 UTC 2023
PRIMARY
SMS_ID
100000084093
Created by admin on Fri Dec 15 18:52:01 UTC 2023 , Edited by admin on Fri Dec 15 18:52:01 UTC 2023
PRIMARY
NCI_THESAURUS
C152297
Created by admin on Fri Dec 15 18:52:01 UTC 2023 , Edited by admin on Fri Dec 15 18:52:01 UTC 2023
PRIMARY
DRUG BANK
DB01347
Created by admin on Fri Dec 15 18:52:01 UTC 2023 , Edited by admin on Fri Dec 15 18:52:01 UTC 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
TARGET -> INHIBITOR
Related Record Type Details
ACTIVE MOIETY